AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04692480 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Breastfeeding Video Education
Description: Video entitled Breastfeeding in the First Hour, It's in Your Hands
Study NCT04692480 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Breastfeeding PDF education
Description: PDF of standard breastfeeding education handouts
Study NCT03943264 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XPro1595
Description: XPro1595 will be delivered by subcutaneous injection once a week
Study NCT02199353 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stimulation of Activities Daily Living
Description: Experimental group: SADL programme which is a new treatment approach created by the authors of this study for the training of ADL through cognitive intervention. The programme is based on the reestablishment of the cognitive functions implied in the performance of basic activities of daily living.~The treatment was carried out twice a week (Tuesday and Thursday) for 45 minutes during 5 weeks.
Study NCT02199353 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional ADLOccupational Therapy
Description: Control group treatment: conventional occupational therapy intervention for the management of ADL deficits. The compensation approach was used and environment modifications and simplification of activities were applied as the intervention method.~The treatment was carried out twice a week (Tuesday and Thursday) for 45 minutes during 5 weeks.
Study NCT03111472 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self-management guide for people with Parkinson's who fall and their informal caregivers
Description: The self-management guide will be developed utilising information from people with Parkinson's, informal caregivers of people with Parkinson's, healthcare professionals and a systematic review of self-management interventions for people with Parkinson's who fall.
Study NCT04386226 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Advanced Ambrotose
Description: Advanced Ambrotose contains aloe vera extract inner leaf gel, arabinogalactan, ghatti gum, glucosamine hydrogen chloride, gum tragacanth, vitamin A, beta carotene, wakame algae extract, and rice starch
Study NCT04386226 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Maltodextrin
Study NCT00545350 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fall prevention exercise program
Description: Weekly physical exercise sessions in small groups, led by a qualified and specially trained instructor, and supplemented by simple exercises to do at home.~The exercise program will focus on progressive balance retraining but will also include strength/resistance, coordination and flexibility training exercises.
Study NCT03428672 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: total hip arthroplasty
Description: Bone samples from Hip fracture were collected from the femoral head which has been replaced
Study NCT03428672 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: total hip arthroplasty
Description: Bone samples from Hip fracture were collected from the femoral head which has been replaced
Study NCT00790231 — intervention group
Intervention type: DEVICE
Intervention: urodynamic procedure
Description: introduction of the urodynamic catheter into the bladder and assessment of the bladder function
Study NCT04284930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Depobupivacaine
Description: surgeons receive schematic for injection of Depobupivacaine. Subjects receive an injection of 166mg depobupivacaine. Injection on either side of the suture line, injected directly into the fascia.
Study NCT04284930 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: OnQ pump
Description: group 2: Surgeons receive instruction sheet with specific placement of catheter. All patients have two OnQ soaker catheters installed into abdominal donor site before donor closure.
Study NCT04284930 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.25% Bupivacaine
Description: group 3: given 0.25% bupivacaine without epinephrine between internal oblique and transverse abdominal muscle.
Study NCT00055770 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: erlotinib hydrochloride
Description: Given orally
Study NCT00055770 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: docetaxel
Description: Given IV
Study NCT00055770 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT00055770 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacological study
Description: Correlative studies
Study NCT00804102 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcorneal Electrical Stimulation
Description: Neurostimulator drives Dawson-Trick-Litzkow electrode attached to patient eye. Different modi are used to stimulate patients.
Study NCT00804102 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: DTL-electrode attached without energy
Description: DTL-electrode attached to patient eye receives no energy from neurostimulator. Treatment times remain the same as used for each treatment arm.
Study NCT01789411 — intervention group
Intervention type: OTHER
Intervention: Drawing blood samples
Description: Drawing blood samples from the arterial sheath prior to the standard coronary angiography procedure
Study NCT01789411 — intervention group
Intervention type: DEVICE
Intervention: Coronary intravascular ultrasound imaging
Description: Coronary intravascular ultrasound imaging of a non-culprit coronary artery.
Study NCT01789411 — intervention group
Intervention type: DEVICE
Intervention: Coronary near-infrared spectroscopy
Description: Near-infrared spectroscopy imaging of a non-culprit coronary artery (in patient who are included in the AtheroRemo-NIRS substudy).
Study NCT03317223 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CJ-12420/Clarithromycin/Amoxicillin
Description: CJ-12420 or Lansoprazole +Clarithromycin/Amoxicillin will be administrated twice a day, for 7 days
Study NCT03317223 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: CJ-12420/Clarithromycin/Amoxicillin
Description: CJ-12420 or Lansoprazole +Clarithromycin/Amoxicillin will be administrated twice a day, for 7 days
Study NCT00185510 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylprednisolone Aceponate (Advantan, BAY86-4862)
Description: In maintenance phase, Methylprednisolone Aceponate cream is applied topically twice a week.
Study NCT00185510 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 2 days a week Vehicle (Advabase)
Study NCT01380301 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Miltefosine and antimony
Description: Short course (half of each drug) administered simultaneously
Study NCT01380301 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Miltefosine alone
Description: short course (half)
Study NCT02746913 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Urodynamics
Description: Urodynamics is performed with the Aquarius XT Laborie system and a fluoroscopic images are obtained with a GE OCE 9800 c-arm fluoroscopy unit. Urodynamic testing will be performed in a seated position with a pessary from the ambulatory pessary trial in place. Post residual void will be measured at the start of the urodynamics.
Study NCT02746913 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pessary
Description: A pessary is a silicone disc that is used in to support the uterus and vagina of women with vaginal prolapse. During this study, the pessary that will be used is a ring with support. This is a disc shape with a membrane stretched across the center. It is a device used in standard practice and is safe to keep in place for up to 3 months at a time. The subjects will be fit with a pessary asked to wear the pessary for 3 days.
Study NCT02039661 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine Spray
Description: These patients received 2 puff lidocaine spray
Study NCT02039661 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02823964 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liprotamase
Description: Oral, soluble, non-enterically coated, non-porcine, pancreatic enzyme replacement
Study NCT02481401 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intensive Individual Intervention Program
Study NCT02481401 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Peer-To-Peer Program Intervention
Study NCT01645878 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: hands on
Description: in hands on group it was instructed by direct help of instructor, mothers could ask questions and if necessary it was done again by researcher.
Study NCT01645878 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: hands off
Description: In hands off group, was instructed by pictures, if mothers had questions, they could watch the pictures again
Study NCT01645878 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: routin breast feeding education
Study NCT03391544 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: V4c toric ICL implantation surgery
Description: The size and power of the V4c toric ICL were determined following the manufacturer's guidelines using a modified vertex formula. Emmetropia was the target refraction following surgery in all cases. Before surgery, three centration points were marked using the slit lamp while the patient, in sitting position, fixated on the center of the slit-lamp beam, which was narrowed as much as possible.
Study NCT04703374 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-382(formulation I)
Description: 1 tablet administered under fasting condition for 7days
Study NCT04703374 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-382(formulation II)
Description: 1 tablet administered under fasting condition for 7days
Study NCT04703374 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D026
Description: 1 tablet administered under fasting condition for 7days
Study NCT01345981 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine
Description: dosage 20 mg and 40 mg
Study NCT01345981 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Lidocaine
Description: dosage 20 mg and 40 mg
Study NCT04028427 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Values-plus-goals intervention
Description: The VGI is a four-week intervention, adapted from an existing online value-affirmation and goals intervention (Kingston \& Ellett, 2014) and an existing 'Living Well with Physical Health Conditions' programme handbook. Participants are first introduced to the concept of values as understood in Acceptance and Commitment Therapy. They are then asked to complete a card-sort task, which involves organising ten life domains according to their perceived level of importance. Participants will be asked to choose one values that is the most important and meaningful to them and to write for up to 10 minutes about it, thinking about why it is meaningful to them. Following this, participants will be given information on how to set value-based 'SMART' goals and asked to choose one to focus on over the next month. Participants will be sent a reminder e-mail every week over the 4 weeks, asking them to review their progress towards the SMART goal they set themselves.
Study NCT04028427 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention
Description: The MBI is a four-week intervention, where participants are introduced to the concept of mindfulness and acceptance as understood in ACT (Hayes et al., 1999). They will be asked to complete a 10-minute health-focused mindfulness meditation exercise by listening to a recording of a script focusing on cultivating mindful awareness of internal experiences, particularly in relation to diabetes, and practising making room for any difficult internal experiences. This will be followed by some prompts to promote reflections related to their diabetes following the exercise. They will be asked to practise this exercise 3-4 times a week over a four-week period. As a manipulation check, participants will be sent a reminder e-mail every week over the four weeks to record how many times they practised the exercise over the past week.
Study NCT01065376 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: the timing cabergoline administration
Description: received 0.5 mg oral cabergoline per day for 8 days on the day of hCG
Study NCT01065376 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: the timing cabergoline administration
Description: received 0.5 mg oral cabergoline per day for 8 days on the day after oocyte retrieval
Study NCT02683655 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apatinib
Description: Apatinib 500mg qd p.o.
Study NCT02683655 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apatinib
Description: Apatinib 750mg qd p.o.
Study NCT03538977 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hydrotherapy
Description: A re-sterilizable stainless steel bucket with an upper diameter of 30 cm, a depth of 32 cm, with water at a temperature between 37 and 38º Celsius will be used. The amount of water used will be sufficient to keep the baby submerged up to shoulder height. The baby will be immersed in the heated water of the bucket and will be suspended by occipital support performed by the physiotherapist, who alternates lateral-lateral and anteroposterior movements with only static suspension. The therapy will last from eight to ten minutes and will be discontinued if there is agitation, cyanosis, worsening respiratory distress or major evacuation. If the baby is using any type of ventilatory support or oxygen therapy, the same will be maintained during the procedure of hydrotherapy.
Study NCT03538977 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Physiotherapy
Description: Conventional physiotherapy consists of manipulations of Thoracoabdominal Rebalancing, a registered technique which uses simultaneous passive stretching of inspiratory muscles and stimulation of the diaphragm. The manipulation used to improve the dynamic diaphragm included the thoracic-abdominal and lower abdominal support maneuvers. Back repositioning was used to minimize posteriorization of the ribs and costal kyphosis due to thoracic distortion.
Study NCT02327338 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: thermacare heat wraps
Description: off the shelf thermacare continuous heat wraps made by thermacare to produce low level heat on the neck
Study NCT02327338 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: thermacare heat wraps
Description: off the shelf thermacare continuous heat wraps made by thermacare to produce low level heat on the neck
Study NCT02327338 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Description: 1200 mg ibuprofen administered 400mg at 4 hour intervals
Study NCT02327338 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Ibuprofen
Description: 1200 mg ibuprofen administered 400mg at 4 hour intervals
Study NCT01603745 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Zoely
Description: 1 pill every day
Study NCT03579914 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: intravenous Placebo
Description: Patients receive intravenous Placebo (saline) injection
Study NCT01603745 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Yasmin
Description: 1 pill every day
Study NCT01383629 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Counselling
Description: Preoperative counselling
Study NCT04737395 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: upper extremity training program (Meditouch,MSQUARE)
Description: 40 hours of therapy with the Hand Tutor (MediTouch) device and a wearable vest (EkssoUE, Ekso Bionics) for arm rehabilitation
Study NCT03579914 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metoprolol Injectable Product
Description: Patients receive intravenous Metoprolol injection
Study NCT03579914 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Romote Ischemic Conditioning (RIC)
Description: Patients receive RIC treatment
Study NCT03579914 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Metoprolol & RIC
Description: Patients receive Metoprolol \& RIC treatment
Study NCT02233920 — intervention group
Intervention type: DRUG
Intervention: Ventilat® - metered dose inhaler
Study NCT02406079 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: tracheotomy
Description: Tracheotomy is one of most performed surgical procedures to assure airway by making a hole in front of the trachea in ICU.
Study NCT02062073 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Abametapir Lotion 0.74% w/w
Study NCT02062073 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: 0.1% sodium lauryl sulfate
Study NCT02062073 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: saline 0.9%
Study NCT02062073 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle Lotion
Study NCT02901119 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Whey protein
Description: Patients, maintaining their regular usual diet, are submitted to a protein supplementation, during 15 days. They recieve 20g packages of whey protein or casein, to take twice a day: 20g in the morning and 20g at night.
Study NCT02901119 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Whey protein
Description: Patients, maintaining their regular usual diet, are submitted to a protein supplementation, during 15 days. They recieve 20g packages of whey protein or casein, to take twice a day: 20g in the morning and 20g at night.
Study NCT00542906 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: localization
Description: localization of the several types of somatosensory stimuli
Study NCT02057029 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: BCI Assay Results
Description: The nature of the intervention is to utilize the BCI results in the decision making process for ER-positive breast cancer patients and their physicians.
Study NCT03330262 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BALCAP prosthesis
Description: The noninvasive BALCAP prosthesis offers uses six degrees-of-freedom (6-DOF) sensing to detect postural imbalance and actuate low-amplitude vibrotactile cues directly to the head to provide the wearer with feedback concerning head tilt in the pitch and roll plane.
Study NCT00355576 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Celecoxib
Description: Celecoxib 400 mg BID with creatine 10 g BID if randomized to the Celecoxib + Creatine study arm.
Study NCT00355576 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Creatine
Description: 10 g BID for either study arm
Study NCT00355576 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minocycline
Description: Minocycline 100 mg BID with creatine 10 g BID if randomized to the Minocycline + Creatine study arm
Study NCT02343445 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: P-1037
Description: P-1037 is a novel ENaC inhibitor
Study NCT02343445 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Hypertonic Saline
Description: 4.2% saline solution
Study NCT02343445 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hypertonic Saline
Description: 4.2% saline solution
Study NCT02343445 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saline
Description: 0.17% saline solution
Study NCT02343445 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: 0.17% saline solution
Study NCT01585662 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: EUS-guided pancreatic pseudocyst drainage
Description: EUS-guided pancreatic pseudocyst drainage by one 8 French naso-pancreatic tube or 2-3 two pig tails- stents.
Study NCT00191282 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin lispro
Description: Patient adjusted dose, three times a day (TID), injected subcutaneous (SC) before each meal until patient completes study
Study NCT00191282 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Human insulin isophane suspension (NPH)
Description: Patient adjusted dose, daily at bedtime, injected subcutaneous (SC) until patient completes study. To be added to the arm only if patient has two consecutive HbA1c values >8.0%
Study NCT00191282 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin glargine
Description: Insulin glargine injected subcutaneous (SC) once daily in the evening until patient completes study.
Study NCT00191282 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Human insulin isophane suspension
Description: Patient adjusted dose, twice daily, injected subcutaneous (SC) before morning and evening meals until patient completes study.
Study NCT00191282 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Human insulin 30/70
Description: Patient adjusted dose, twice daily before the morning and evening meals, injected subcutaneous (SC) until patient completes study. To replace insulin regimen in this arm only if patient has two consecutive HbA1c values >8.0%.
Study NCT02689869 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibrutinib
Description: Ibrutinib (PCI-32765; JNJ-54179060) is a first-in-class, potent, orally-administered covalently-binding small molecule inhibitor of Bruton's tyrosine kinase currently being co-developed by Janssen Research \& Development, LLC and Pharmacyclics, Inc for the treatment of B-cell malignancies.